JD.com Wins 'Grade A' Online Drug Sales Certification
36Kr.com, 12/26/14
China's State Food and Drug Administration has announced that it has issued a "Grade A Online Drug Sales Platform" certification to Beijing-based B2C e-commerce platform JD.com (Nasdaq: JD). The platform is the third to receive the "Grade A" certificate alongside Alibaba Group's (NYSE: BABA) B2C e-commerce site Tmall and Chinese B2C online retailer Yihaodian.
A "Grade A" certification allows platforms to work with approved drug manufacturers, drug distributors and medical institutions.
JD.com previously focused its energies on the sale of healthcare products which did not require licenses. In 2014 the website section entitled "Healthcare" was renamed "Healthcare and Medical Treatment" in anticipation of making online drug sales.
In 2013 Tmall held almost half of China's online drug sales market. In September 2014 the firm achieved RMB 66 mln in online drug sales, and sales on China's annual November 11 "Singles Day" e-commerce shopping holiday grew 315% from the previous year.
Keywords: online healthcare e-commerce Internet certification B2C State Food and Drug Administration JD.com JD
Sending
